Orthocell

Industry Lists

Orthocell (ASX: OCC) is a bio-therapeutic company dedicated to improvement of the lives of people suffering from soft tissue injuries by providing innovative approaches to the regeneration of tendon, cartilage and soft tissue injuries.

Contact Details

Building 191 Murdoch University, South Street, MURDOCH WA 6150

08 9360 2888

celltherapy@orthocell.com.au

www.orthocell.com.au

Lists and Charts

Share Price

Closing price for the last 90 trading days

View Full Chart

Share Transactions

23/09/21

$200k Sold

Stewart Washer

23/09/21

$344k Sold

Paul Anderson

23/09/21

$208k Sold

Paul Anderson

Total value as at the date of the transaction

Revenue

Rank	Company	Revenue
158^th	Orthocell	$1.1m
175^th	Douugh	$337k
176^th	Nanollose	$323k
179^th	Syntonic	$239k
180^th	Neurotech International	$226k

View Full List

208 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®

Total Shareholder Return as at 29/04/22

Rank	Company	1 yr	5 yr
896^th	Syntonic	0%	-47%
1001^st	Nanollose	-6%
1240^th	Neurotech International	-23%	-26%
1241^st	Orthocell	-23%	-0%
1899^th	Douugh	-83%	-6%

1811 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Collapse All Lists and Charts

Company Activity

	NEWS: Tagged in Medical research, innovation, priorities for government	14 Jun 2021
	NEWS: Tagged in Perron and UWA to reap $70m windfall	01 Jun 2021
	NEWS: Tagged in US approval for Orthocell regeneration product	14 Jan 2021
	NEW ROLE: Simon Robertson, Company Secretary	24 Nov 2020
	REMUNERATION UPDATE: Lars Lidgren, Non-Executive Director	02 Nov 2020
	REMUNERATION UPDATE: Stewart Washer, Executive Chair	02 Nov 2020
	REMUNERATION UPDATE: Qi Xiao Zhou, Non-Executive Director	02 Nov 2020
	REMUNERATION UPDATE: Paul Anderson, Founder, Managing Director	02 Nov 2020
	REMUNERATION UPDATE: Stewart Washer, Executive Chair	24 Aug 2020
	REMUNERATION UPDATE: Paul Anderson, Founder, Managing Director	24 Aug 2020